Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase EARLY_PHASE1 2

Status

Withdrawn 1Unknown 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other 1

Conditions

Polycystic Ovary Syndrome 2Obesity 1

Interventions

Metformin 6Spironolactone 4ganirelix 3Progesterone 3Pioglitazone 2Ovidrel 2Methyltestosterone 2Hydrocortisone 2Estradiol 2Cosyntropin 2Thyrotropin 1Testosterone 1Ortho Evra 1Luteinizing Hormone 1Leuprolide 1LHRH, Ac-Nal(1)-Cpa(2)-Trp(3)-Arg(6)-Ala(10)- 1Inositol 1Flutamide 1Dexamethasone 1Contraception 1Body Mass Index 1Blood Urea Nitrogen 1Adrenocorticotropic Hormone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Polycystic Ovary Syndrome × Cosyntropin × Clear all
NCT03905603 2023-11-03

SHK001

University of Virginia

Phase EARLY_PHASE1 Unknown
144 enrolled

Polycystic Ovary Syndrome

NCT01422733 2018-07-19

Effect of Longer-term Adrenal Suppression Using Low Dose Hydrocortisone on Androgen Overproduction

University of Virginia

Phase EARLY_PHASE1 Withdrawn
Other

Obesity, Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡